Eupraxia Pharmaceuticals Alpha and Beta Analysis

EPRXFDelisted Stock  USD 2.79  0.04  1.45%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eupraxia Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eupraxia Pharmaceuticals over a specified time horizon. Remember, high Eupraxia Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eupraxia Pharmaceuticals' market risk premium analysis include:
Beta
1.06
Alpha
(0.84)
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Eupraxia Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Eupraxia Pharmaceuticals did 0.84  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Eupraxia Pharmaceuticals stock's relative risk over its benchmark. Eupraxia Pharmaceuticals has a beta of 1.06  . Eupraxia Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Eupraxia Pharmaceuticals is expected to follow. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Eupraxia Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eupraxia Pharmaceuticals market risk premium is the additional return an investor will receive from holding Eupraxia Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eupraxia Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eupraxia Pharmaceuticals' performance over market.
α-0.84   β1.06

Eupraxia Pharmaceuticals Fundamentals Vs Peers

Comparing Eupraxia Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eupraxia Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Eupraxia Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eupraxia Pharmaceuticals or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Eupraxia Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Eupraxia Pharmaceuticals to competition
FundamentalsEupraxia PharmaceuticalsPeer Average
Return On Equity-0.89-0.31
Return On Asset-0.33-0.14
Current Valuation43.78 M16.62 B
Shares Outstanding21.39 M571.82 M
Shares Owned By Insiders12.40 %10.09 %
Shares Owned By Institutions20.24 %39.21 %
Price To Book3.89 X9.51 X

Eupraxia Pharmaceuticals Opportunities

Eupraxia Pharmaceuticals Return and Market Media

The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  

About Eupraxia Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eupraxia or other pink sheets. Alpha measures the amount that position in Eupraxia Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eupraxia Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eupraxia Pharmaceuticals' short interest history, or implied volatility extrapolated from Eupraxia Pharmaceuticals options trading.

Build Portfolio with Eupraxia Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Eupraxia Pink Sheet

If you are still planning to invest in Eupraxia Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eupraxia Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios